DRUG REPURPOSING AND COMPUTATIONAL DRUG DISCOVERY FOR DIABETES

Abstract

The emergence of advanced molecular modeling software and speedy processing units has transformed the research of drug discovery in diabetes concerning type 2 diabetes mellitus (T2DM). This review highlights the recent advances and significance of in silico modeling for designing potential anti-T2DM drugs. The authors have discussed currently available information on the study of molecular modeling methods like molecular docking and drug repurposing for designing antiT2DM drugs. Also, the authors have tried to present the limitations of in silico molecular modeling in T2DM drug discovery